Liana Fraenkel, MD, MPH
Dr. Fraenkel ([email protected]) is currently Professor of Medicine and Associate Program Director, Section of Rheumatology, Yale School of Medicine. She is Section Chief of Rheumatology at the VA Connecticut Healthcare System and founder and Co- Director of the VA Bone and Joint Center. Dr. Fraenkel has served on the ACR Guideline subcommittee and is currently Chair of the ACR Quality of Care committee. Dr. Liana Fraenkel graduated from McGill University Medical School after which she pursued her internal medicine training and was Chief Medical Resident at the Montreal General Hospital. Dr. Fraenkel subsequently pursued rheumatology training at Boston University where she completed a Masters of Public Health under the mentorship of Dr. David Felson. After completing her fellowship training, Dr. Fraenkel was recruited to the Yale University School of Medicine, where she has developed a research career focused on medical decision making and risk communication.Dr. Fraenkel has a strong interest in mentoring. She is currently funded by a NIAMS K24 Award which provides support to enable her to mentor rheumatology fellows training for a career in clinical investigation. She also serves as a standing member of the NIH AMS NIAMS Review Panel. Dr. Fraenkel’s research interest is in developing robust and practical methods to elicit patient treatment preferences and to improve medical decision-making. Dr. Fraenkel and her husband, David Oelberg, live in Newtown.
When asked, “Why is patient-centered and patient-powered research necessary in order to advance our understanding of rheumatological conditions?”, Dr. Fraenkel responded,
“Numerous studies have demonstrated that patients with rheumatologic conditions approach treatment decisions and value risk benefit trade-offs differently than physicians. Therefore, incorporating the patient’s perspective into all aspects of clinical research (from study design to implementation) is critical to ensure relevance, buy-in and ultimately improvement of meaningful outcomes.”